InMed Pharmaceuticals Advances Neurodegenerative Disease

Targeting neurodegenerative diseases such as Alzheimer’s, Huntington’s and Parkinson’sIdentified two lead cannabinoid analog compounds for in vivo...

Related Keywords

United Kingdom ,Vancouver ,British Columbia ,Canada ,British ,Eric Hsu ,Ujendra Kumar ,Colin Clancy ,Inmed Pharmaceuticals ,Company Nasdaq ,Alliance Grant Funding ,Pharmaceuticals Sciences ,Exchange Commission ,University Of British Columbia ,A Neurodegenerative Disease Program ,Inmed Pharmaceuticals Inc ,Preclinical Research Development ,Med Pharmaceuticals ,Senior Vice President ,Preclinical Research ,Note Regarding Forward Looking Information ,Neurodegenerative Disease Program ,Grant Funding ,Annual Report ,Nasdaq Inm ,Nmed Pharmaceuticals Inc ,